UNIVERSITY OF SYDNEY

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: -

Established: 1850-01-01

Employees: -

Market Cap: -

Website: https://www.sydney.edu.au/

Clinical Trials

Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.

Not Applicable

Completed

Conditions: Melanoma (Skin)

Interventions: Behavioral: Clinician-led surveillance
Device: Patient-led surveillance

First Posted Date: 2018-07-10

Last Posted Date: 2023-08-01

Lead Sponsor: University of Sydney

Target Recruit Count: 100

Registration Number: NCT03581188

Locations: 🇦🇺
Newcastle Skin Check, Newcastle, New South Wales, Australia
🇦🇺
Melanoma Institute Australia, North Sydney, New South Wales, Australia
🇦🇺
Royal Prince Alfred Hospital, Sydney, New South Wales, Australia

Composition of Functional Tooth Units and Nutrient Intake in Older Men

Completed

Conditions: Dietary Assessment of Older Men
Oral Health of Older Men

First Posted Date: 2017-09-27

Last Posted Date: 2017-09-27

Lead Sponsor: University of Sydney

Target Recruit Count: 781

Registration Number: NCT03295435

Locations: 🇦🇺
The Centre for Education and Research on Ageing, Sydney, New South Wales, Australia

Evaluation of a Patient-Reported Symptom Index for NMIBC

Completed

Conditions: Superficial Bladder Cancer

First Posted Date: 2017-03-27

Last Posted Date: 2021-10-13

Lead Sponsor: University of Sydney

Target Recruit Count: 498

Registration Number: NCT03091764

Locations: 🇦🇺
Royal North Shore Hospital, St Leonards, New South Wales, Australia
🇺🇸
University of Kansas, Kansas City, Kansas, United States
🇦🇺
Concord Hospital, Concord, New South Wales, Australia

and more 16 locations

Prophylactic Early PN in HPT/BMT

Not Applicable

Conditions: Hematologic Neoplasms

Interventions: Dietary Supplement: Parenteral nutrition.
Other: Pragmatic standard care.

First Posted Date: 2017-03-20

Last Posted Date: 2021-04-28

Lead Sponsor: University of Sydney

Target Recruit Count: 408

Registration Number: NCT03083327

Locations: 🇦🇺
Royal North Shore Hospital, Sydney, New South Wales, Australia
🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇳🇿
Christchurch Hospital, CDHB, Christchurch, New Zealand

PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns

Phase 3

Completed

Conditions: Hypoxic-Ischemic Encephalopathy

Interventions: Drug: Epoetin Alfa
Drug: Normal saline

First Posted Date: 2017-03-14

Last Posted Date: 2024-06-05

Lead Sponsor: University of Sydney

Target Recruit Count: 313

Registration Number: NCT03079167

Locations: 🇦🇺
Flinders Medical Centre, Bedford Park, South Australia, Australia
🇦🇺
The Royal Women's Hospital, Parkville, Victoria, Australia
🇸🇬
KK Women's and Children's Hospital, Singapore, Singapore

and more 21 locations

Patient Experience and Acceptance of Horizontal Rotation

Not Applicable

Recruiting

Conditions: Cancer

Interventions: Device: Nano-X patient rotation

First Posted Date: 2016-12-16

Last Posted Date: 2024-07-03

Lead Sponsor: University of Sydney

Target Recruit Count: 100

Registration Number: NCT02995603

Locations: 🇦🇺
Prince of Wales Hospital, Randwick, New South Wales, Australia

Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)

Not Applicable

Active, not recruiting

Conditions: Liver Cancer

Interventions: Device: Kilovoltage Intrafraction Monitoring

First Posted Date: 2016-12-07

Last Posted Date: 2024-02-13

Lead Sponsor: University of Sydney

Target Recruit Count: 32

Registration Number: NCT02984566

Locations: 🇦🇺
Westmead Hospital, Westmead, New South Wales, Australia
🇦🇺
Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
🇦🇺
Nepean Hospital, Penrith, New South Wales, Australia

and more 1 locations

Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer

Phase 3

Active, not recruiting

Conditions: Bladder Cancer

Interventions: Biological: Bacillus of Calmette-Guerin (BCG)
Drug: Mitomycin (MM)

First Posted Date: 2016-10-28

Last Posted Date: 2023-06-18

Lead Sponsor: University of Sydney

Target Recruit Count: 501

Registration Number: NCT02948543

Locations: 🇬🇧
Nottingham City Hospital - City Campus, Nottingham, United Kingdom
🇦🇺
Fiona Stanley Hospital, Murdoch, Western Australia, Australia
🇦🇺
Concord Repatriation General Hospital, Concord, New South Wales, Australia

and more 14 locations

Infection and Tumour Antigen Cellular Therapy

Phase 1

Conditions: Leukemia, Myelocytic, Acute

Interventions: Biological: Donor-derived WT1-CTL and P-CTL

First Posted Date: 2016-09-09

Last Posted Date: 2016-09-09

Lead Sponsor: University of Sydney

Target Recruit Count: 20

Registration Number: NCT02895412

Locations: 🇦🇺
Westmead Hospital, Westmead, Sydney, New South Wales, Australia

Breast Radiotherapy Audio Visual Enhancement for Sparing the Heart

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Device: Breathe Well
Device: RPM

First Posted Date: 2016-08-26

Last Posted Date: 2023-07-27

Lead Sponsor: University of Sydney

Target Recruit Count: 45

Registration Number: NCT02881203

Locations: 🇦🇺
Royal North Shore Hospital, St Leonards, New South Wales, Australia

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy